Nonfatal Overdoses in Emergency Departments: Bridging Patient Characteristics, Biospecimen Toxicology, and Drug Supply Composition
Office of National Drug Control Policy · Opportunity number EDS-EDS-26-001
Details summarized from the official notice as of Sep 1, 2026. Always confirm eligibility, deadlines and requirements in the official notice before applying.
Independent platform. Not affiliated with or endorsed by any government agency. Data from public federal sources.
Key facts
| Opportunity number | EDS-EDS-26-001 |
|---|---|
| Agency | Office of National Drug Control Policy Office of National Drug Control Policy |
| Assistance listing (ALN, formerly CFDA) | 95.007 |
| Posted | Aug 12, 2026 |
| Deadline | Aug 31, 2026 |
| Award ceiling | $500,000 |
| Award floor | $1 |
| Expected number of awards | 1 |
| Cost sharing or matching required | No |
| Funding type | Cooperative agreement |
| Category | Health |
| Last updated here | Sep 1, 2026 |
Summary from the notice
Who can apply
The official notice lists these applicant types as eligible:
- Public and state colleges and universities
- Nonprofits with 501(c)(3) status (other than colleges)
Who should take a closer look
- Nonprofits
- Colleges and universities
Not listed as eligible
- Small businesses
- State governments
- Local governments
- Tribal governments and organizations
- Larger for-profit companies
- Individuals
Unless the eligibility text in the notice names you, this opportunity is probably not for you.
Registrations you will likely need
Most applications submitted through Grants.gov need the following. Registration can take several weeks, so start early. The notice lists the exact requirements.
- SAM.gov registration for your organization, which also gives you a Unique Entity ID (UEI). Registration is free.
- A Login.gov account, which Grants.gov uses for sign-in.
- A Grants.gov applicant registration linked to your organization's UEI.
Related open opportunities
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)
National Institutes of Health · PAR-25-077
Strengthening Ghana Health Service laboratory services, diagnostic networks, and systems for a more effective, efficient, and sustainable response to HIV, TB, and other priority health threats
Centers for Disease Control-GHC · CDC-RFA-JG-26-0178
Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
National Institutes of Health · PAR-25-155
Community Engagement Evaluation and Data Coordination (CEED) Hub to Advance Data and Practice Transformation for Optimizing Oral Health for All (U01, Clinical Trial Not Allowed)
National Institutes of Health · RFA-DE-27-001
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
National Institutes of Health · RFA-CA-27-021